Report copyright - DISCUSIÓN · FIRE-3 study design FOLFIRI + Cetuximab Cetuximab: 400 mg/m2 i.v. 120min initial dose 2250 mg/m i.v. 60min q 1w FOLFIRI + Bevacizumab Bevacizumab: 5 mg/kg i.v. 30-90min
Please pass captcha verification before submit form